An open label, randomised, four period, partial crossover study to evaluate the absolute bioavailability and effect of food on the pharmacokientics of oral/I.V. Odanacatib in healthy postmenopausal women

Trial Profile

An open label, randomised, four period, partial crossover study to evaluate the absolute bioavailability and effect of food on the pharmacokientics of oral/I.V. Odanacatib in healthy postmenopausal women

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Aug 2016

At a glance

  • Drugs Odanacatib (Primary) ; Odanacatib (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 23 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top